Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Danial E Baker

doi:10.1310/hpj5005-416

Back

Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Journal article

Open access

Peer reviewed

Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Danial E Baker

Hospital pharmacy (Philadelphia), Vol.50(5), pp.416-422

05/2015

DOI: https://doi.org/10.1310/hpj5005-416

Handle:

https://hdl.handle.net/2376/112727

PMCID: PMC4567208

PMID: 26405328

Files and links (1)

url

https://doi.org/10.1310/hpj5005-416View

Published (Version of record) Open

Abstract

Current FDA-Related Drug Information

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at danial.baker@wsu.edu .

Metrics

3 Record Views

Details

Title: Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Creators: Danial E Baker - Director
Publication Details: Hospital pharmacy (Philadelphia), Vol.50(5), pp.416-422
Academic Unit: Pharmacotherapy, Department of
Publisher: Thomas Land Publishers, Inc
Identifiers: 99900547892401842
Language: English
Resource Type: Journal article